3137 WPI Pill - white capsule/oblong, 18mm
Pill with imprint 3137 WPI is White, Capsule/Oblong and has been identified as Nizatidine 150 mg. It is supplied by Watson Pharmaceuticals.
Nizatidine is used in the treatment of Erosive Esophagitis; GERD; Duodenal Ulcer; Indigestion; Duodenal Ulcer Prophylaxis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 3137 WPI
Nizatidine
- Imprint
- 3137 WPI
- Strength
- 150 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- National Drug Code (NDC)
- 00591-3137
- Inactive Ingredients
-
silicon dioxide,
corn starch,
croscarmellose sodium,
magnesium stearate,
ammonia,
ferrosoferric oxide,
gelatin,
potassium hydroxide,
propylene glycol,
shellac,
sodium lauryl sulfate,
titanium dioxide,
D&C Yellow No. 10,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
More about nizatidine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (12)
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: H2 antagonists
- Breastfeeding
- En español
Patient resources
- Nizatidine drug information
- Nizatidine (Advanced Reading)
- Nizatidine Capsules and Tablets
- Nizatidine Oral Solution
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
